Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Tolerability of needle-free ZINGO™, (lidocaine hydrochloride monohydrate) Powder Intradermal Injection System 0.5 mg, in pediatric patients undergoing venipuncture or peripheral venous cannulation: The COMFORT-003 and COMFORT-004 Trials

Krane EJ, Zempsky WT, Schmitz ML, Yu KP, on behalf of the COMFORT Study Investigators. Tolerability of needle-free ZINGO™, (lidocaine hydrochloride monohydrate) Powder Intradermal Injection System 0.5 mg, in pediatric patients undergoing venipuncture or peripheral venous cannulation: The COMFORT-003 and COMFORT-004 Trials. American College of Emergency Physicians Scientific Assembly.


collapse authors with profiles